XOMA Royalty Corp. Files 8-K on Financials
Ticker: XOMAP · Form: 8-K · Filed: Aug 13, 2025 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Royalty Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Aug 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0075, $0.05 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, corporate-structure
TL;DR
XOMA Royalty Corp. filed an 8-K on Aug 13, 2025, updating its financial reporting and preferred stock details.
AI Summary
On August 13, 2025, XOMA Royalty Corp. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, including details on its preferred stock series. No specific new financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing provides an update on XOMA Royalty Corp.'s financial reporting and corporate structure, which is important for investors to understand the company's current status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing financial condition and exhibits, with no immediate negative or positive operational news.
Key Players & Entities
- XOMA Royalty Corp. (company) — Filer of the 8-K report
- August 13, 2025 (date) — Date of the earliest event reported
- NV (state) — State of incorporation
- 510-204-7239 (phone_number) — Business phone number
FAQ
What is the primary purpose of this 8-K filing by XOMA Royalty Corp.?
The primary purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.
On what date was this 8-K report filed or effective?
The report was filed as of August 13, 2025, and the date of the earliest event reported is also August 13, 2025.
What is XOMA Royalty Corp.'s Standard Industrial Classification code?
XOMA Royalty Corp.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is XOMA Royalty Corp.'s fiscal year end?
XOMA Royalty Corp.'s fiscal year ends on December 31.
What are some of the preferred stock series mentioned in relation to XOMA Royalty Corp.?
The filing mentions 'M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShare' and 'DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShare'.
Filing Stats: 578 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-08-13 07:45:38
Key Financial Figures
- $0.0075 — nge on which registered: Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
Filing Documents
- d852650d8k.htm (8-K) — 29KB
- d852650dex991.htm (EX-99.1) — 160KB
- g852650g0813042619962.jpg (GRAPHIC) — 7KB
- 0001193125-25-179446.txt ( ) — 376KB
- xoma-20250813.xsd (EX-101.SCH) — 4KB
- xoma-20250813_def.xml (EX-101.DEF) — 14KB
- xoma-20250813_lab.xml (EX-101.LAB) — 24KB
- xoma-20250813_pre.xml (EX-101.PRE) — 15KB
- d852650d8k_htm.xml (XML) — 8KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . Number Description of Document 99.1 Press release entitled "XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements" dated August 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA ROYALTY CORPORATION Date: August 13, 2025 By: /s/ Thomas Burns Thomas Burns Senior Vice President, Finance and Chief Financial Officer